Feb. 20, 2018 | Truly good ideas like the one around which InterveXion was built have staying power. Since InterveXion was established as a company in 2004, granting agencies and others have continued to value both the company and its mission. BioVentures from the first saw merit in the new treatment for methamphetamine abuse developed [...]
Feb. 13, 2018 | Increasing success in preventing injuries to patients in falling accidents has resulted in ever rising licensing revenue for HD Nursing, a company started with help from BioVentures at UAMS. “By the end of 2016, we were at about $250,000,” said Amy Hester, Ph.D., R.N., chief scientific officer for HD Nursing. “We [...]
Oct. 12, 2017 | Led by UAMS researchers, a new clinical study called STAMPOUT aims to help a drug user stay in treatment by keeping the effects of the drug from going into the brain. This month, the National Institutes of Health (NIH) National Institute on Drug Abuse awarded the InterveXion/UAMS research team an $8 [...]
June 14, 2017 | Potential patents for medical inventions as small as a molecule prompted big discussions among UAMS researchers who gathered for a showcase hosted June 6 by the College of Medicine to highlight medical research. “Every poster you see here today has a patent application on file with the Patent and Trademark Office,” [...]
May 12, 2017 | BioVentures recently earned the University of Arkansas for Medical Sciences (UAMS) a national ranking by the Milken Institute of 87th out of 225 universities for technology transfer — the ability to take basic research and develop it into new technologies, products and companies. UAMS ranked above several well-known institutions, including the [...]
April 27, 2017 | Arkansas college students interested in learning the fundamentals of entrepreneurship and forming new health science ventures at a residential boot camp at the University of Central Arkansas (UCA) in Conway have until May 7 to register. Held from May 22-26, the camp is a joint initiative of the University of Arkansas for [...]
Oct. 21, 2016 | To bring life to a state’s life sciences sector, working together is key, and the Arkansas Life Sciences Summit keynote speaker Patrick Plues could see that spirit in abundance as he looked at his audience. About 100 entrepreneurs, investors and research scientists gathered at the summit in Conway on Oct. 19 [...]
LITTLE ROCK – Omnibalm Daily Foot Therapy, a cream for general and diabetic foot care developed at the University of Arkansas for Medical Sciences (UAMS), holds promise as a treatment for preventing the recurrence of lower extremity ulcers in diabetic patients, a pilot study indicates.
LITTLE ROCK — Nancy M. Gray, Ph.D., has been named director of UAMS BioVentures, the technology licensing office and business incubator for the University of Arkansas for Medical Sciences (UAMS).
InterveXion Therapeutics, a UAMS Startup, Receives $14.5 Million to Develop Drug Therapies for Methamphetamine Users
LITTLE ROCK – A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.